View source for Plasma cell

{{Short description|White blood cell that secretes large volumes of antibodies}}
{{Distinguish|blood plasma}}
{{Infobox cell
| Name        = Plasma cell
| Latin       = plasmocytus
| Image       = Plasmacytoma ultramini1.jpg
| Caption     = Micrograph of malignant '''plasma cells''' ([[plasmacytoma]]), many displaying characteristic "clockface nuclei", also seen in normal plasma cells. [[H&E stain]].
| Image2      = Plasmacell.jpg
| Caption2    = Micrograph of a plasma cell with distinct clear perinuclear region of the cytoplasm, which contains large numbers of [[Golgi bodies]].
| Precursor   =
| System      = [[Lymphatic system]]
}}

'''Plasma cells''', also called '''plasma B cells''' or '''effector B cells''', are [[white blood cells]] that originate in the [[lymphoid organs]] as [[B cell]]s<ref>Guyton and Hall Textbook of Medical Physiology 14th edition: unit 6, chapter 35.</ref><ref>{{Cite web|url=https://www.sciencedirect.com/topics/medicine-and-dentistry/plasma-cell|title = Plasma Cell - an overview &#124; ScienceDirect Topics}}</ref> and secrete large quantities of proteins called [[antibodies]] in response to being presented specific substances called [[antigen]]s. These antibodies are transported from the plasma cells by the [[blood plasma]] and the [[lymphatic system]] to the site of the target antigen (foreign substance), where they initiate its neutralization or destruction. B cells differentiate into plasma cells that produce antibody molecules closely modeled after the receptors of the precursor B cell.<ref>{{cite web|url=https://www.britannica.com/science/plasma-cell|title=Plasma cell - biology|website=britannica.com}}</ref>

== Structure ==
[[File:Dutcher and Russell bodies.jpg|thumb|left|Plasma cells with [[Russell bodies|Dutcher and Russell bodies]] ([[H&E stain]], 100×, oil)]]

Plasma cells are large [[lymphocyte]]s with abundant [[cytoplasm]] and a characteristic appearance on [[light microscopy]]. They have [[basophilic]] cytoplasm and an eccentric nucleus with [[heterochromatin]] in a characteristic cartwheel or clock face arrangement. Their cytoplasm also contains a pale zone that on [[electron microscopy]] contains an extensive [[Golgi apparatus]] and [[centriole]]s. Abundant [[rough endoplasmic reticulum]] combined with a well-developed Golgi apparatus makes plasma cells well-suited for secreting immunoglobulins.<ref>{{cite web |title=Plasma Cell - LabCE.com, Laboratory Continuing Education |url=https://www.labce.com/spg448425_plasma_cell.aspx |website=www.labce.com |access-date=2 June 2018}}</ref> Other [[organelle]]s in a plasma cell include ribosomes, lysosomes, mitochondria, and the plasma membrane.{{citation needed|date=January 2023}}

===Surface antigens===
Terminally differentiated plasma cells express relatively few surface antigens, and do not express common pan-B cell markers, such as [[CD19]] and [[CD20]]. Instead, plasma cells are identified through [[flow cytometry]] by their additional expression of [[CD138]], [[CD78]], and the [[Interleukin-6 receptor]]. In humans, [[CD27]] is a good marker for plasma cells; naïve B cells are CD27−, memory B-cells are CD27+ and plasma cells are CD27++.<ref name=Bona>{{cite book | vauthors = Bona C, Bonilla FA, Soohoo M | title = Textbook of Immunology | edition = 2 | year = 1996 | publisher = CRC Press | isbn = 978-3-7186-0596-5 | chapter = 5 | page = 102 }}</ref>

The surface antigen [[CD138]] (syndecan-1) is expressed at high levels.<ref name="pmid18770841">{{cite journal | vauthors = Rawstron AC | title = Immunophenotyping of plasma cells | journal = Current Protocols in Cytometry | volume = Chapter 6 | pages = Unit6.23 | date = May 2006 | pmid = 18770841 | doi = 10.1002/0471142956.cy0623s36 | isbn = 0-471-14295-6 | series = Chapter | s2cid = 19511070 }}</ref>

Another important surface antigen is [[CD319]] (SLAMF7). This antigen is expressed at high levels on normal human plasma cells. It is also expressed on malignant plasma cells in multiple myeloma. Compared with CD138, which disappears rapidly ex vivo, the expression of CD319 is considerably more stable.<ref name="pmid24385542">{{cite journal | vauthors = Frigyesi I, Adolfsson J, Ali M, Christophersen MK, Johnsson E, Turesson I, Gullberg U, Hansson M, Nilsson B | display-authors = 6 | title = Robust isolation of malignant plasma cells in multiple myeloma | journal = Blood | volume = 123 | issue = 9 | pages = 1336–40 | date = February 2014 | pmid = 24385542 | doi = 10.1182/blood-2013-09-529800 | doi-access = free }}</ref>

== Development ==
After leaving the bone marrow, the B cell acts as an [[antigen-presenting cell]] (APC) and internalizes offending antigens, which are taken up by the B cell through [[receptor-mediated endocytosis]] and processed. Pieces of the antigen (which are now known as ''antigenic peptides'') are loaded onto [[MHC II]] molecules, and presented on its extracellular surface to [[CD4+ T cells]] (sometimes called ''T helper cells''). These T cells bind to the MHC II-antigen molecule and cause activation of the B cell. This is a type of safeguard to the system, similar to a [[two-factor authentication]] method. First, the B cells must encounter a foreign antigen and are then required to be activated by T helper cells before they differentiate into specific cells.<ref>{{Cite book |last=Hoffbrand |first=A. V. |url=https://www.worldcat.org/oclc/768731797 |title=Essential haematology |date=2011 |publisher=Wiley-Blackwell |others=P. A. H. Moss, J. E. Pettit |isbn=978-1-118-29397-3 |edition=6th |location=Malden, Mass. |chapter=Chapter 9 White Cells: Lymphocytes |oclc=768731797}}</ref>

Upon stimulation by a T cell, which usually occurs in [[germinal center]]s of [[secondary lymphoid organ]]s such as the [[spleen]] and [[lymph nodes]], the activated B cell begins to differentiate into more specialized cells. [[Germinal center]] B cells may differentiate into [[memory B cells]] or plasma cells.  Most of these B cells will become plasmablasts (or "immature plasma cells"), and eventually plasma cells, and begin producing large volumes of antibodies. Some B cells will undergo a process known as [[affinity maturation]].<ref name="Neuberger-2004">{{cite book | vauthors = Neuberger MS, Honjo T, Alt FW |title=Molecular biology of B cells |publisher=Elsevier |location=Amsterdam |year=2004 |pages=189–191 |isbn=0-12-053641-2 }}</ref> This process favors, by selection for the ability to bind antigen with higher affinity, the activation and growth of B cell clones able to secrete antibodies of higher affinity for the antigen.<ref name="Merino Tejero-2020">{{Cite journal |last1=Merino Tejero |first1=Elena |last2=Lashgari |first2=Danial |last3=García-Valiente |first3=Rodrigo |last4=Gao |first4=Xuefeng |last5=Crauste |first5=Fabien |last6=Robert |first6=Philippe A. |last7=Meyer-Hermann |first7=Michael |last8=Martínez |first8=María Rodríguez |last9=van Ham |first9=S. Marieke |last10=Guikema |first10=Jeroen E. J. |last11=Hoefsloot |first11=Huub |last12=van Kampen |first12=Antoine H. C. |date=2020 |title=Multiscale Modeling of Germinal Center Recapitulates the Temporal Transition From Memory B Cells to Plasma Cells Differentiation as Regulated by Antigen Affinity-Based Tfh Cell Help |journal=Frontiers in Immunology |volume=11 |pages=620716 |doi=10.3389/fimmu.2020.620716 |issn=1664-3224 |pmc=7892951 |pmid=33613551|doi-access=free }}</ref>

===Immature plasma cells===
[[File:Plasmablast, Wright stain.png|thumb|Plasmablast, [[Wright stain]].]]
The most immature blood cell that is considered of plasma cell lineage is the plasmablast.<ref name="isbn0-7817-6507-2">{{cite book | vauthors = Glader B, Greer JG, Foerster J, Rodgers GC, Paraskevas F |title=Wintrobe's Clinical Hematology, 2-Vol. Set |publisher=Lippincott Williams & Wilkins |location=Hagerstwon, MD |year=2008 |pages=347 |isbn=978-0-7817-6507-7 }}</ref> Plasmablasts secrete more antibodies than B cells, but less than plasma cells.<ref name="Walport-2008">{{cite book |vauthors = Walport M, Murphy K, Janeway C, Travers PJ |title=Janeway's immunobiology |publisher=Garland Science |location=New York |year=2008 |pages=[https://archive.org/details/janewaysimmunobi00murp/page/387 387–388] |isbn=978-0-8153-4123-9 |url-access=registration |url=https://archive.org/details/janewaysimmunobi00murp/page/387 }}</ref> They divide rapidly and are still capable of internalizing antigens and presenting them to T cells.<ref name="Walport-2008" /> A cell may stay in this state for several days, and then either die or irrevocably differentiate into a mature, fully differentiated plasma cell.<ref name="Walport-2008" /> Differentiation of mature B cells into plasma cells is dependent upon the transcription factors [[Blimp-1]]/[[PRDM1]], [[BCL6]], and [[IRF4]].<ref name="Merino Tejero-2020" />

== Function ==
Unlike their precursors, plasma cells cannot [[immunoglobulin class switching|switch antibody classes]], cannot act as antigen-presenting cells because they no longer display MHC-II, and do not take up antigen because they no longer display significant quantities of immunoglobulin on the cell surface.<ref name="Walport-2008" /> However, continued exposure to antigen through those low levels of immunoglobulin is important, as it partly determines the cell's lifespan.<ref name="Walport-2008" />

The lifespan, class of antibodies produced, and the location that the plasma cell moves to also depends on signals, such as [[cytokines]], received from the T cell during differentiation.<ref name="Caligaris-Cappio-1997" /> Differentiation through a T cell-independent antigen stimulation (stimulation of a B cell that does not require the involvement of a T cell) can happen anywhere in the body<ref name="Neuberger-2004"/> and results in short-lived cells that secrete IgM antibodies.<ref name="Caligaris-Cappio-1997" /> The T cell-dependent processes are subdivided into primary and secondary responses: a primary response (meaning that the T cell is present at the time of initial contact by the B cell with the antigen) produces short-lived cells that remain in the extramedullary regions of lymph nodes; a secondary response produces longer-lived cells that produce IgG and IgA, and frequently travel to the bone marrow.<ref name="Caligaris-Cappio-1997">{{cite book | vauthors = Caligaris-Cappio F, Ferrarini M |title=Human B Cell Populations (Chemical Immunology) | volume = 67 |publisher=S. Karger AG (Switzerland) |year=1997 |pages=103–104 |isbn=3-8055-6460-0 }}</ref> For example, plasma cells will likely secrete [[IgG3]] antibodies if they matured in the presence of the cytokine [[interferon-gamma]]. Since B cell maturation also involves [[somatic hypermutation]] (a process completed before differentiation into a plasma cell), these antibodies frequently have a very high affinity for their antigen.{{cn|date=May 2024}}

Plasma cells can only produce a single kind of antibody in a single class of immunoglobulin. In other words, every B cell is specific to a single antigen, but each cell can produce several thousand matching antibodies per second.<ref name="isbn0-323-01639-1">{{cite book | vauthors = Kierszenbaum AL |title=Histology and cell biology: an introduction to pathology |publisher=Mosby |location=St. Louis |year=2002 |pages=275 |isbn=0-323-01639-1 }}</ref> This prolific production of antibodies is an integral part of the [[humoral immune response]].{{cn|date=May 2024}}

=== Long-lived plasma cells ===
{{main|Long-lived plasma cell}}
The current findings suggest that after the process of affinity maturation in germinal centers, plasma cells develop into one of two types of cells: short-lived plasma cells (SLPC) or [[long-lived plasma cell]]s (LLPC). LLPC mainly reside in the bone marrow for a long period of time and secrete antibodies, thus providing long-term protection. LLPC can maintain antibody production for decades or even for the lifetime of an individual,<ref>{{cite journal | vauthors = Slifka MK, Matloubian M, Ahmed R | title = Bone marrow is a major site of long-term antibody production after acute viral infection | journal = Journal of Virology | volume = 69 | issue = 3 | pages = 1895–902 | date = March 1995 | pmid = 7853531 | doi = 10.1128/jvi.69.3.1895-1902.1995 | pmc = 188803 }}</ref><ref>{{Cite journal |last1=Radbruch|first1=Andreas|last2=Muehlinghaus|first2=Gwendolin|last3=Luger|first3=Elke O.|last4=Inamine|first4=Ayako|last5=Smith|first5=Kenneth G. C.|last6=Dörner|first6=Thomas|last7=Hiepe|first7=Falk|date=October 2006|title=Competence and competition: the challenge of becoming a long-lived plasma cell|url=http://www.nature.com/articles/nri1886|journal=Nature Reviews Immunology|language=en|volume=6|issue=10|pages=741–750|doi=10.1038/nri1886|pmid=16977339|s2cid=23664563|issn=1474-1733|url-access=subscription}}</ref> and, unlike B cells, LLPC do not need antigen restimulation to generate antibodies. Human LLPC population can be identified as [[CD19|CD19<sup>–</sup>]] [[CD38|CD38<sup>hi</sup>]] [[CD138|CD138<sup>+</sup>]] cells.<ref>{{cite journal | vauthors = Halliley JL, Tipton CM, Liesveld J, Rosenberg AF, Darce J, Gregoretti IV, Popova L, Kaminiski D, Fucile CF, Albizua I, Kyu S, Chiang KY, Bradley KT, Burack R, Slifka M, Hammarlund E, Wu H, Zhao L, Walsh EE, Falsey AR, Randall TD, Cheung WC, Sanz I, Lee FE | display-authors = 6 | title = Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow | journal = Immunity | volume = 43 | issue = 1 | pages = 132–45 | date = July 2015 | pmid = 26187412 | pmc = 4680845 | doi = 10.1016/j.immuni.2015.06.016 }}</ref>

The long-term survival of LLPC are dependent on a specific environment in the bone marrow, the plasma cell survival niche.<ref>{{cite journal | vauthors = Manz RA, Radbruch A | title = Plasma cells for a lifetime? | journal = European Journal of Immunology | volume = 32 | issue = 4 | pages = 923–7 | date = April 2002 | pmid = 11920557 | doi = 10.1002/1521-4141(200204)32:4<923::aid-immu923>3.0.co;2-1 | doi-access = free }}</ref> Removal of an LLPC from its survival niche results in its rapid death. A survival niche can only support limited number of LLPC, thus the niche's environment must protect its LLPC cells but be able to accept new arrivals.<ref>{{Cite journal|last1=Nguyen|first1=Doan C.|last2=Joyner|first2=Chester J.|last3=Sanz|first3=Iñaki|last4=Lee|first4=F. Eun-Hyung|date=2019-09-11|title=Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells|journal=Frontiers in Immunology|volume=10|pages=2138|doi=10.3389/fimmu.2019.02138|issn=1664-3224|pmc=6749102|pmid=31572364|doi-access=free}}</ref><ref>{{Cite journal|last=Tangye|first=Stuart G.|date=December 2011|title=Staying alive: regulation of plasma cell survival|journal=Trends in Immunology|language=en|volume=32|issue=12|pages=595–602|doi=10.1016/j.it.2011.09.001|pmid=22001488|doi-access=free}}</ref> The plasma cell survival niche is defined by a combination of cellular and molecular factors and though it has yet to be properly defined, molecules such as [[Interleukin 5|IL-5]], [[Interleukin 6|IL-6]], [[Tumor necrosis factor|TNF-α]], [[Stromal cell-derived factor 1|stromal cell-derived factor-1α]] and signalling via [[CD44]] have been shown to play a role in the survival of LLPC.<ref>{{cite journal|display-authors=6|vauthors=Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, Muehlinghaus G, Szyska M, Radbruch A, Manz RA|date=August 2003|title=Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals|journal=Journal of Immunology|volume=171|issue=4|pages=1684–90|doi=10.4049/jimmunol.171.4.1684|pmid=12902466|doi-access=free}}</ref> LLPC can also be found, to a lesser degree, in [[gut-associated lymphoid tissue]] (GALT), where they produce [[Immunoglobulin A|IgA]] antibodies and contribute to mucosal immunity. Recent findings suggest that plasma cells in the gut do not necessarily need to be generated ''de novo'' from active B cells but there are also long-lived PC, suggesting the existence of a similar survival niche.<ref>{{cite journal | vauthors = Lemke A, Kraft M, Roth K, Riedel R, Lammerding D, Hauser AE | title = Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice | journal = Mucosal Immunology | volume = 9 | issue = 1 | pages = 83–97 | date = January 2016 | pmid = 25943272 | doi = 10.1038/mi.2015.38 | doi-access = free }}</ref> Tissue specific niches that allow for the survival of LLPC have been also described in nasal-associated lymphoid tissues (NALT), human tonsillar lymphoid tissues and human mucosa or mucosa-associated lymphoid tissues (MALT).<ref>{{Cite journal|last1=Liang|first1=Bin|last2=Hyland|first2=Lisa|last3=Hou|first3=Sam|date=June 2001|title=Nasal-Associated Lymphoid Tissue Is a Site of Long-Term Virus-Specific Antibody Production following Respiratory Virus Infection of Mice|journal=Journal of Virology|language=en|volume=75|issue=11|pages=5416–5420|doi=10.1128/JVI.75.11.5416-5420.2001|issn=0022-538X|pmc=114951|pmid=11333927}}</ref><ref>{{Cite journal|last1=van Laar|first1=Jacob M.|last2=Melchers|first2=Marc|last3=Teng|first3=Y. K. Onno|last4=van der Zouwen|first4=Boris|last5=Mohammadi|first5=Rozbeh|last6=Fischer|first6=Randy|last7=Margolis|first7=Leonid|last8=Fitzgerald|first8=Wendy|last9=Grivel|first9=Jean-Charles|last10=Breedveld|first10=Ferdinand C.|last11=Lipsky|first11=Peter E.|date=September 2007|title=Sustained Secretion of Immunoglobulin by Long-Lived Human Tonsil Plasma Cells|journal=The American Journal of Pathology|language=en|volume=171|issue=3|pages=917–927|doi=10.2353/ajpath.2007.070005|pmc=1959503|pmid=17690187}}</ref><ref>{{Cite journal|last1=Huard|first1=Bertrand|last2=McKee|first2=Thomas|last3=Bosshard|first3=Carine|last4=Durual|first4=Stéphane|last5=Matthes|first5=Thomas|last6=Myit|first6=Samir|last7=Donze|first7=Olivier|last8=Frossard|first8=Christophe|last9=Chizzolini|first9=Carlo|last10=Favre|first10=Christiane|last11=Zubler|first11=Rudolf|date=2008-07-01|title=APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa|url=http://www.jci.org/articles/view/33760|journal=Journal of Clinical Investigation|volume=118|issue=8|language=en|pages=2887–2895|doi=10.1172/JCI33760|issn=0021-9738|pmc=2447926|pmid=18618015}}</ref><ref>{{Cite journal|last1=Lemke|first1=A|last2=Kraft|first2=M|last3=Roth|first3=K|last4=Riedel|first4=R|last5=Lammerding|first5=D|last6=Hauser|first6=A E|date=January 2016|title=Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice|journal=Mucosal Immunology|language=en|volume=9|issue=1|pages=83–97|doi=10.1038/mi.2015.38|pmid=25943272|issn=1933-0219|doi-access=free}}</ref>

Originally it was thought that the continuous production of antibodies is a result of constant replenishment of short-lived plasma cells by memory B cell re-stimulation. Recent findings, however, show that some PC are truly long-lived. The absence of antigens and the depletion of B cells does not appear to have an effect on the production of high-affinity antibodies by the LLPC. Prolonged depletion of B cells (with anti-CD20 monoclonal antibody treatment that affects B cells but not PC) also did not affect antibody titres.<ref>{{cite journal | vauthors = Slifka MK, Antia R, Whitmire JK, Ahmed R | title = Humoral immunity due to long-lived plasma cells | journal = Immunity | volume = 8 | issue = 3 | pages = 363–72 | date = March 1998 | pmid = 9529153 | doi = 10.1016/S1074-7613(00)80541-5 | doi-access = free }}</ref><ref>{{cite journal | vauthors = DiLillo DJ, Hamaguchi Y, Ueda Y, Yang K, Uchida J, Haas KM, Kelsoe G, Tedder TF | display-authors = 6 | title = Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice | journal = Journal of Immunology | volume = 180 | issue = 1 | pages = 361–71 | date = January 2008 | pmid = 18097037 | doi = 10.4049/jimmunol.180.1.361 | doi-access = free }}</ref><ref>{{cite journal | vauthors = Ahuja A, Anderson SM, Khalil A, Shlomchik MJ | title = Maintenance of the plasma cell pool is independent of memory B cells | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 105 | issue = 12 | pages = 4802–7 | date = March 2008 | pmid = 18339801 | pmc = 2290811 | doi = 10.1073/pnas.0800555105 | bibcode = 2008PNAS..105.4802A | doi-access = free }}</ref> LLPC secrete high levels of [[Immunoglobulin G|IgG]] independently of B cells. LLPC in bone marrow are the main source of circulating IgG in humans.<ref>{{cite journal | vauthors = Longmire RL, McMillan R, Yelenosky R, Armstrong S, Lang JE, Craddock CG | title = In vitro splenic IgG synthesis in Hodgkin's disease | journal = The New England Journal of Medicine | volume = 289 | issue = 15 | pages = 763–7 | date = October 1973 | pmid = 4542304 | doi = 10.1056/nejm197310112891501 }}</ref> Even though IgA production is traditionally associated with mucosal sites, some plasma cells in bone marrow also produce IgA.<ref>{{cite journal | vauthors = Mei HE, Yoshida T, Sime W, Hiepe F, Thiele K, Manz RA, Radbruch A, Dörner T | display-authors = 6 | title = Blood-borne human plasma cells in steady state are derived from mucosal immune responses | journal = Blood | volume = 113 | issue = 11 | pages = 2461–9 | date = March 2009 | pmid = 18987362 | doi = 10.1182/blood-2008-04-153544 | doi-access = free }}</ref> LLPC in bone marrow have been observed producing [[Immunoglobulin M|IgM]].<ref>{{cite journal | vauthors = Bohannon C, Powers R, Satyabhama L, Cui A, Tipton C, Michaeli M, Skountzou I, Mittler RS, Kleinstein SH, Mehr R, Lee FE, Sanz I, Jacob J | display-authors = 6 | title = Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection | journal = Nature Communications | volume = 7 | issue = 1 | pages = 11826 | date = June 2016 | pmid = 27270306 | pmc = 4899631 | doi = 10.1038/ncomms11826 | bibcode = 2016NatCo...711826B }}</ref>

==Clinical significance==
[[Plasmacytoma]], [[multiple myeloma]], [[Waldenström macroglobulinemia]], [[heavy chain disease]], and [[plasma cell leukemia]] are [[cancer]]s of the plasma cells.<ref>{{DorlandsDict|nine/000951264|Plasma cell}}</ref> Multiple myeloma is frequently identified because malignant plasma cells continue producing an antibody, which can be detected as a [[paraprotein]]. [[Monoclonal gammopathy of undetermined significance|Monoclonal gammopathy of undetermined significance (MGUS)]] is a plasma cell dyscrasia characterized by the secretion of a myeloma protein into the blood and may lead to multiple myeloma.<ref>{{Cite journal |last1=Agarwal |first1=Amit |last2=Ghobrial |first2=Irene M. |date=2013-03-01 |title=Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease |journal=Clinical Cancer Research|volume=19 |issue=5 |pages=985–994 |doi=10.1158/1078-0432.CCR-12-2922 |issn=1557-3265 |pmc=3593941 |pmid=23224402}}</ref>

[[Common variable immunodeficiency]] is thought to be due to a problem in the [[cellular differentiation|differentiation]] from lymphocytes to plasma cells. The result is a low serum antibody level and risk of infections.{{cn|date=May 2024}}

[[AL amyloidosis|Primary amyloidosis (AL)]] is caused by the deposition of excess immunoglobulin light chains which are secreted from plasma cells.{{cn|date=May 2024}}

== See also ==
* [[Leukocyte]]
* [[Plasma cell dyscrasia]]
* [[List of distinct cell types in the adult human body]]

== References ==
{{Reflist}}

== External links ==
* {{BUHistology|21001loa}}
* [https://web.archive.org/web/20060927161741/http://www.wadsworth.org/chemheme/heme/microscope/plasmacell.htm Histology at wadsworth.org]

{{Lymphocytes}}
{{Lymphocytic immune system}}
{{Abnormal clinical and laboratory findings for blood}}
{{Authority control}}

{{DEFAULTSORT:Plasma Cell}}
[[Category:B cells]]
[[Category:Connective tissue cells]]
[[Category:Human cells]]
[[Category:Immune system]]
[[Category:Immunology]]
[[Category:Lymphocytes]]